BLUE Archived Articles
bluebird bio, Inc. (NASDAQ:BLUE): Can This Gene Therapy Pioneer Overcome its Challenges?
Published on March 08, 2025
bluebird bio (NASDAQ:BLUE): A Pioneering Gene Therapy Leader Navigating Uncharted Territories
Published on November 05, 2024
bluebird bio, Inc. (NASDAQ:BLUE) - Navigating the Gene Therapy Frontier with Precision and Perseverance
Published on September 24, 2024